- Home
- GEL vs XERS Comparison
GEL vs XERS Comparison
Compare GEL & XERS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | GEL | XERS |
|---|---|---|
| Founded | 1996 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil Refining/Marketing | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.9B | 1.6B |
| IPO Year | 1996 | 2021 |
Fundamental Metrics
Financial Performance| Metric | GEL | XERS |
|---|---|---|
| Price | $16.21 | $8.76 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 2 | 6 |
| Target Price | ★ $19.50 | $10.83 |
| AVG Volume (30 Days) | 224.8K | ★ 1.6M |
| Earning Date | 05-07-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.19% | N/A |
| EPS Growth | N/A | ★ 100.00 |
| EPS | ★ 0.21 | N/A |
| Revenue | ★ $2,912,770,000.00 | $49,590,000.00 |
| Revenue This Year | $12.12 | $34.37 |
| Revenue Next Year | N/A | $22.86 |
| P/E Ratio | $77.14 | ★ N/A |
| Revenue Growth | 43.60 | ★ 142.67 |
| 52 Week Low | $13.75 | $5.25 |
| 52 Week High | $18.64 | $10.08 |
Technical Indicators
Market Signals| Indicator | GEL | XERS |
|---|---|---|
| Relative Strength Index (RSI) | 65.25 | 58.70 |
| Support Level | $14.87 | $6.97 |
| Resistance Level | $16.24 | $9.01 |
| Average True Range (ATR) | 0.40 | 0.36 |
| MACD | 0.06 | 0.03 |
| Stochastic Oscillator | 92.31 | 86.75 |
Price Performance
Historical ComparisonAbout GEL Genesis Energy L.P.
Genesis Energy LP focuses on the midstream segment of the crude oil and natural gas industry. It offers various services to crude oil and natural gas producers, and industrial and commercial enterprises. The company's reportable segments are: Offshore pipeline transportation, Marine transportation, and Onshore transportation and services. Maximum revenue is generated from the Offshore pipeline transportation segment, which includes the transportation and processing of crude oil and natural gas in the Gulf of America. The Marine transportation segment provides waterborne transportation of petroleum products and crude oil throughout North America; and the Onshore transportation and services segment deals with crude oil logistics, sour gas processing, and sells sulfur byproducts.
About XERS Xeris Biopharma Holdings Inc.
Xeris Biopharma Holdings Inc is a commercial-stage biopharmaceutical company focused on developing and commercializing therapies for people with chronic endocrine and neurological diseases in the United States. It offers Recorlev for the treatment of endogenous hypercortisolemia in patients with Cushing's syndrome; Gvoke for the treatment of severe hypoglycemia; and Keveyis for the treatment of Primary Periodic Paralysis (PPP). Additionally, the company is advancing its Phase 3-ready pipeline product, XP-8121, a once-weekly subcutaneous injection of levothyroxine, which leverages its proprietary technology, XeriSol.